Does EBV viral capsid IgG usually indicate past infection rather than current replication?

EBV serology is most useful when interpreted as a pattern rather than as a single marker. In a 74-year-old, isolated VCA IgG positivity is generally compatible with remote, established EBV exposure.

Clinical interpretation

• EBV viral capsid antigen (VCA) IgG develops during acute infection, peaks about 2–4 weeks after symptom onset, declines modestly, and typically remains detectable for life.
• Thus, a positive VCA IgG is strong evidence that EBV infection has occurred at some point. A high or persistent titer does not date the infection and is not, on its own, evidence of recent disease.
• The broader serologic pattern matters: VCA IgG plus EBNA IgG generally supports past infection, whereas VCA IgM with absent EBNA is more compatible with primary or recent infection. VCA IgG alone, without IgM and EBNA results, can be temporally indeterminate.

Mechanistic context

• Persistent serum VCA IgG reflects durable humoral immune memory rather than necessarily active viral production.
• EBV itself can persist latently, primarily in largely transcriptionally silent memory B cells. This latent reservoir is biologically distinct from clinically meaningful lytic replication.

Implications for assessing current activity

• VCA IgG should not be used as a standalone test for current EBV replication or reactivation.
• If active EBV-related illness is a clinical concern, interpretation requires symptoms, the complete antibody profile, and sometimes context-specific EBV DNA testing. PCR results also require caution because detectable EBV DNA may reflect latent cell-associated virus, lytic activity, or cellular injury, depending on specimen type and clinical setting.

Bottom line

• The claim is substantially correct: EBV VCA IgG usually persists for life and principally documents established exposure; it does not independently establish the timing or current replicative activity of EBV.